NCT00969761 - BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumour | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

February 29, 2012

Conditions

Neoplasms

Interventions

DRUG

BI-6727

Low to high dose (administered every 3 weeks). Depending on the toxicities observed, intermediary dose levels may be added

DRUG

BI 6727

low to high dose

Trial Locations (2)

1230.6.3201 Boehringer Ingelheim Investigational Site, Brussels

1230.6.3202 Boehringer Ingelheim Investigational Site, Leuven